High expression of stratifin is a universal abnormality during the course of malignant progression of early‐stage lung adenocarcinoma

Adenocarcinoma in situ (AIS) of the lung has an extremely favorable prognosis, with a 5‐year survival rate of 100%. However, early invasive adenocarcinoma (EIA) often has a fatal outcome. In this study, we compared the expression profiles of AIS with those of EIA showing lymph node metastasis or a fatal outcome, and screened the differentially expressed genes by cDNA microarray. From the genes selected, we focused on Stratifin (SFN, 14‐3‐3 σ), which showed significantly higher expression in EIA than in AIS. Immunohistochemistry for SFN revealed that more than 95% of EIAs were immunopositive for SFN, in comparison to only 13% of AISs (p <0.05). Interestingly, positivity was detected not only in the invasive region but also in the in situ spreading component of EIA. Functionally, SFN facilitates the cell proliferation capacity of lung adenocarcinoma. These results indicate that SFN overexpression is a universal abnormality during the stepwise progression from in situ to invasive adenocarcinoma of the lung.

[1]  L. Tanoue.  Cancer Statistics, 2009 , 2010 .

[2]  Chi-Ying F. Huang,et al.  VEGFA Upregulates FLJ10540 and Modulates Migration and Invasion of Lung Cancer via PI3K/AKT Pathway , 2009, PloS one.

[3]  M. Sezer,et al.  High levels of oxidative stress in patients with advanced lung cancer , 2008, Respirology.

[4]  A. Toker,et al.  Akt/PKB Signaling in Cancer: A Function in Cell Motility and Invasion , 2006, Cell cycle.

[5]  M. Noguchi,et al.  Establishment of an immortalized cell line from a precancerous lesion of lung adenocarcinoma, and genes highly expressed in the early stages of lung adenocarcinoma development , 2005, Cancer science.

[6]  R. Margreiter,et al.  14-3-3σ Expression Is an Independent Prognostic Parameter for Poor Survival in Colorectal Carcinoma Patients , 2005, Clinical Cancer Research.

[7]  J. Celis,et al.  Down-regulation of the Tumor Suppressor Protein 14-3-3σ Is a Sporadic Event in Cancer of the Breast , 2005, Molecular & Cellular Proteomics.

[8]  H. Hermeking,et al.  Prostate cancer is characterized by epigenetic silencing of 14-3-3σ expression , 2004, Oncogene.

[9]  D. Leroith,et al.  14-3-3σ Mediation of Cell Cycle Progression Is p53-independent in Response to Insulin-like Growth Factor-I Receptor Activation* , 2004, Journal of Biological Chemistry.

[10]  D. Morrison,et al.  Unlocking the code of 14-3-3 , 2004, Journal of Cell Science.

[11]  T. Nakajima,et al.  Inactivation of 14-3-3sigma by hypermethylation is a rare event in colorectal cancers and its expression may correlate with cell cycle maintenance at the invasion front. , 2004, Cancer letters.

[12]  Kenji Suzuki,et al.  Grade of Stromal Invasion in Small Adenocarcinoma of the Lung: Histopathological Minimal Invasion and Prognosis , 2004, The American journal of surgical pathology.

[13]  H. Hermeking,et al.  Prostate cancer is characterized by epigenetic silencing of 14-3-3sigma expression. , 2004, Oncogene.

[14]  Christine A Iacobuzio-Donahue,et al.  Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies. , 2003, Cancer research.

[15]  H. Hermeking.  The 14-3-3 cancer connection , 2003, Nature Reviews Cancer.

[16]  M. W. Büchler,et al.  Microarray-based identification of differentially expressed growth- and metastasis-associated genes in pancreatic cancer , 2003, Cellular and Molecular Life Sciences CMLS.

[17]  Rork Kuick,et al.  Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. , 2003, Cancer research.

[18]  Teruhiko Yoshida,et al.  A faithful method for PCR-mediated global mRNA amplification and its integration into microarray analysis on laser-captured cells. , 2003, Biochemical and biophysical research communications.

[19]  Richard Paylor,et al.  Behavioral and physiological mouse assays for anxiety: a survey in nine mouse strains , 2002, Behavioural Brain Research.

[20]  Satoshi Inoue,et al.  Efp targets 14-3-3σ for proteolysis and promotes breast tumour growth , 2002, Nature.

[21]  Lewis C Cantley,et al.  The phosphoinositide 3-kinase pathway. , 2002, Science.

[22]  Y. Yatabe,et al.  Frequent and histological type-specific inactivation of 14-3-3σ in human lung cancers , 2002, Oncogene.

[23]  C. Sakakura,et al.  [Overexpression of 14-3-3 in primary gastric cancers and clinical application for the detection of micrometastases in the peritoneal cavity]. , 2002, Nihon Geka Gakkai zasshi.

[24]  B. Gusterson,et al.  Epigenetic inactivation of 14-3-3 sigma in oral carcinoma: association with p16(INK4a) silencing and human papillomavirus negativity. , 2002, Cancer research.

[25]  Satoshi Inoue,et al.  Efp targets 14-3-3 sigma for proteolysis and promotes breast tumour growth. , 2002, Nature.

[26]  S. Sukumar,et al.  Hypermethylation of 14-3-3 σ (stratifin) is an early event in breast cancer , 2001, Oncogene.

[27]  S. Sukumar,et al.  Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer. , 2001, Oncogene.

[28]  Hiromu Suzuki,et al.  Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 σ gene in human hepatocellular carcinoma , 2000, Oncogene.

[29]  M. Toyota,et al.  Inactivation of the 14-3-3 sigma gene is associated with 5' CpG island hypermethylation in human cancers. , 2000, Cancer research.

[30]  Mong-Hong Lee,et al.  Association of the Cyclin-dependent Kinases and 14-3-3 Sigma Negatively Regulates Cell Cycle Progression* , 2000, The Journal of Biological Chemistry.

[31]  E. Dellambra,et al.  Downregulation of 14-3-3σ Prevents Clonal Evolution and Leads to Immortalization of Primary Human Keratinocytes , 2000, The Journal of cell biology.

[32]  T. Pandita,et al.  High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[33]  D. Sivam,et al.  Identification of Genes Overexpressed in Head and Neck Squamous Cell Carcinoma Using a Combination of Complementary DNA Subtraction and Microarray Analysis , 2000, The Laryngoscope.

[34]  Y. Nishiwaki,et al.  Prognostic significance of the size of central fibrosis in peripheral adenocarcinoma of the lung. , 2000, The Annals of thoracic surgery.

[35]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[36]  S. Masters,et al.  14-3-3 proteins: structure, function, and regulation. , 2000, Annual review of pharmacology and toxicology.

[37]  K. Kinzler,et al.  14-3-3σ is required to prevent mitotic catastrophe after DNA damage , 1999, Nature.

[38]  K. Kinzler,et al.  14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage. , 1999, Nature.

[39]  K. Kinzler,et al.  14-3-3σ Is a p53-Regulated Inhibitor of G2/M Progression , 1997 .

[40]  K. Kinzler,et al.  14-3-3sigma is a p53-regulated inhibitor of G2/M progression. , 1997, Molecular cell.

[41]  K. Yasumoto,et al.  Elevated expression levels of the 14-3-3 family of proteins in lung cancer tissues. , 1997, Human antibodies.

[42]  S. Hirohashi,et al.  Small adenocarcinoma of the lung. Histologic characteristics and prognosis. , 1995, Cancer.

[43]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.